Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Senti Biosciences Inc | Timothy Lu | Director, CEO and Interim PFO and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 1,927,073 | 1,927,073 | - | - | Stock Option (Right to Buy) | |
| Starwood Property Trust Inc | Barry S. Sternlicht | Director, CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 1,350,000 | 2,591,668 | - | - | Restricted Stock Units | |
| Cerus Corp | William M. Greenman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 975,000 | 4,205,000 (2%) | 0% | 0 | Common Stock | |
| Boyd Gaming Corp | Marianne Boyd Johnson | Director, Executive Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Mar 2025 | 909,091 | 2,387,949 (2%) | 0% | 0 | Common Stock | |
| Comcast (Class A) | Brian L. Roberts | Director, Chairman of Board & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.72 per share. | 06 Mar 2025 | 907,600 | 7,342,476 (0%) | 0% | 29.7 | 26,978,410 | Class A Common Stock |
| Comcast (Class A) | Brian L. Roberts | Director, Chairman of Board & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 907,600 | 0 | - | - | Option to Purchase | |
| Akari Therapeutics PLC (ADR) | Hoyoung Huh | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 892,857 | 892,857 | - | - | Series B Warrants (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Hoyoung Huh | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 892,857 | 892,857 | - | - | Series A Warrants (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Hoyoung Huh | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 06 Mar 2025 | 892,857 | 4,695,854 (0%) | 0% | 1.1 | 1,000,000 | American Depositary Shares representing Ordinary Shares |
| Comcast (Class A) | Brian L. Roberts | Director, Chairman of Board & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.76 per share. | 06 Mar 2025 | 818,478 | 6,523,998 (0%) | 0% | 35.8 | 29,264,681 | Class A Common Stock |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 750,000 | 750,000 | - | - | Stock Option (Right to Buy) | |
| Burford Cap Ltd | Christopher P. Bogart | Director, Chief Executive Officer | 06 Mar 2025 | 725,349 | 1,762,790 | - | - | Phantom RSUs | ||
| Senti Biosciences Inc | Timothy Lu | Director, CEO and Interim PFO and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 642,358 | 724,440 | - | 0 | Common Stock | |
| Burford Cap Ltd | Jonathan Molot | Chief Investment Officer | 06 Mar 2025 | 637,601 | 1,835,143 | - | - | Phantom RSUs | ||
| Global Indemnity Grp LLC (Class A) | Saul A. Fox | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 550,000 | 550,000 (5%) | 5% | 0 | Class A-2 Common Shares | |
| Global Indemnity Grp LLC (Class A) | Saul A. Fox | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 550,000 | 550,000 (5%) | 5% | 0 | Class A-2 Common Shares | |
| Cerus Corp | Vivek K. Jayaraman | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 545,000 | 1,450,828 (0%) | 0% | 0 | Common Stock | |
| Burford Cap Ltd | Christopher P. Bogart | Director and Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 13.71 per share. | 06 Mar 2025 | 544,012 | 9,746,437 (4%) | 0% | 13.7 | 7,458,405 | Ords |
| Akari Therapeutics PLC (ADR) | Raymond Prudo-Chlebosz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 446,428 | 446,428 | - | - | Series A Warrants (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Raymond Prudo-Chlebosz | Director | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 06 Mar 2025 | 446,428 | 2,484,990 (0%) | 0% | 1.1 | 499,999 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics PLC (ADR) | Raymond Prudo-Chlebosz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 446,428 | 446,428 | - | - | Series B Warrants (Right to Buy) | |
| Walmart | C. Douglas McMillon | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 443,394 | 4,001,641 (0%) | 0% | 0 | Common Stock | |
| D-Wave Quantum Inc | John M. Markovich | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 430,360 | 1,494,916 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| LifeStance Health Grp Inc | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 423,790 | 3,571,480 | - | 0 | Common Stock | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 06 Mar 2025 | 406,250 | 3,031,005 (0%) | 0% | 1.1 | 455,000 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 406,250 | 406,250 | - | - | Series A Warrants (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 406,250 | 406,250 | - | - | Series B Warrants (Right to Buy) | |
| Cerus Corp | Kevin D. Green | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 392,500 | 886,362 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp | Chrystal Jensen | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 385,000 | 790,198 (0%) | 0% | 0 | Common Stock | |
| Viatris | Scott A. Smith | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 373,555 | 373,555 | - | - | Restricted Stock Units | |
| Fastly Inc (Class A) | Todd Nightingale | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 362,513 | 1,979,433 (2%) | 0% | 0 | Class A Common Stock | |
| Pixelworks Inc | Todd A. Debonis | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 350,000 | 2,082,600 (5%) | 0% | - | Common Stock | |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 348,985 | 782,841 | - | 0 | Common Stock | |
| Nano Nuclear Energy Inc | Florent Heidet | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 338,000 | 0 | - | - | Stock Options (right to purchase) | |
| Boyd Gaming Corp | Marianne Boyd Johnson | Director, Executive Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Mar 2025 | 300,000 | 1,604,379 (1%) | 0% | 0 | Common Stock | |
| Boyd Gaming Corp | William R. Boyd | Director | Other type of transaction at price $ 0.00 per share. | 06 Mar 2025 | 300,000 | 1,780,447 (1%) | 0% | 0 | Common Stock | |
| Cerus Corp | Richard J. Benjamin | Chief Medical Officer | 06 Mar 2025 | 300,000 | 694,373 (0%) | 0% | 0 | Common Stock | ||
| Indie Semiconductor Inc (Class A) | Donald McClymont | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 286,500 | 286,500 | - | - | Performance-based Restricted Stock Units | |
| LifeStance Health Grp Inc | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 283,172 | 3,259,120 | - | 0 | Common Stock | |
| Emergent Biosolutions Inc | Joseph C. Papa | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 282,500 | 1,032,500 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Joseph C. Papa | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 282,500 | 282,500 (0%) | 0% | 0 | Common Stock | |
| AMBAC Fin Grp Inc | Claude L. LeBlanc | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 274,612 | 661,355 | - | - | Deferred Share Units | |
| Amylyx Pharma Inc | Joshua Cohen | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 270,177 | 270,177 | - | - | Stock Option (Right to Buy) | |
| Amylyx Pharma Inc | Justin Klee | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 270,177 | 270,177 | - | - | Stock Option (right to buy) | |
| 4D Molecular Therapeutics Inc | David Kirn | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 267,500 | 267,500 | - | - | Stock Option (Right to Buy) | |
| Arlo Tech Inc | Matthew McRae | Director, CEO | Sale of securities on an exchange or to another person at price $ 11.79 per share. | 06 Mar 2025 | 259,227 | 2,686,678 (3%) | 0% | 11.8 | 3,056,649 | Common Stock |
| Arlo Tech Inc | Matthew McRae | Director, CEO | Sale of securities on an exchange or to another person at price $ 12.03 per share. | 06 Mar 2025 | 259,227 | 2,945,905 (3%) | 0% | 12.0 | 3,117,282 | Common Stock |
| TaskUs Inc (Class A) | Bryce Maddock | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 243,614 | 243,614 | - | - | Restricted Stock Units | |
| Sana biotech Inc | Bernard J. Cassidy | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 240,000 | 240,000 | - | - | Stock Option (Right to Buy) | |
| Senti Biosciences Inc | Kanya Rajangam | Pres. & Chief Med. & Dev. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 235,088 | 235,088 | - | - | Stock Option (Right to Buy) | |
| Medpace Holdings Inc | August J. Troendle | Director, CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 234,259 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Medpace Holdings Inc | August J. Troendle | Director, CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.61 per share. | 06 Mar 2025 | 234,259 | 926,332 (2%) | 0% | 56.6 | 13,261,402 | Common Stock |
| Walmart | Suresh Kumar | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 215,177 | 1,532,930 (0%) | 0% | 0 | Common | |
| Archrock Inc | D. Bradley Childers | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 214,030 | 2,330,727 (1%) | 0% | 0 | Common Stock | |
| Archrock Inc | D. Bradley Childers | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 214,030 | 0 | - | - | Performance Share Units | |
| Walmart | John R. Furner | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 213,617 | 674,289 (0%) | 0% | 0 | Common | |
| Pixelworks Inc | Haley F. Green | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 200,000 | 552,607 (1%) | 0% | - | Common Stock | |
| Arlo Tech Inc | Matthew McRae | Director, CEO | Sale of securities on an exchange or to another person at price $ 11.04 per share. | 06 Mar 2025 | 200,000 | 2,486,678 (3%) | 0% | 11.0 | 2,207,180 | Common Stock |
| Walmart | Kathryn McLay | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 199,444 | 892,309 (0%) | 0% | 0 | Common | |
| Solid Power Inc (Class A) | Joshua R. Buettner-Garrett | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 187,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Solid Power Inc (Class A) | Joshua R. Buettner-Garrett | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 06 Mar 2025 | 187,500 | 1,052,804 | - | 0.0 | 5,625 | Common Stock |
| Solid Power Inc (Class A) | Joshua R. Buettner-Garrett | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 06 Mar 2025 | 187,500 | 865,304 | - | 1.1 | 211,556 | Common Stock |
| Peloton Interactive Inc | Jennifer Cunningham Cotter | Chief Content Officer | 06 Mar 2025 | 187,238 | 100,269 (0%) | 0% | 6.5 | 1,208,228 | Class A Common Stock | |
| Sera Prognostics Inc (Class A) | Zhenya Lindgardt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 181,380 | 181,380 | - | - | Stock Option (right to buy) | |
| Walmart | John David Rainey | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 180,943 | 400,224 (0%) | 0% | 0 | Common | |
| Amylyx Pharma Inc | Joshua Cohen | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 180,118 | 3,376,770 | - | 0 | Common Stock | |
| Amylyx Pharma Inc | Justin Klee | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 180,118 | 3,376,766 | - | 0 | Common Stock | |
| Emergent Biosolutions Inc | Richard S. Lindahl | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 178,546 | 484,490 | - | - | Employee Stock Options (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Fariborz Kamal | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 178,400 | 178,400 | - | - | Stock Option (Right to Buy) | |
| Commerce.com Inc - Ordinary Shares Series 1 | Ellen F. Siminoff | Director | Purchase of securities on an exchange or from another person at price $ 6.64 per share. | 06 Mar 2025 | 177,158 | 253,333 | - | 6.6 | 1,176,382 | Series 1 Common Stock |
| CCC Intelligent Soln Holdings Inc | Brian Herb | See Remarks | 06 Mar 2025 | 171,123 | 171,123 | - | - | Restricted Stock Unit | ||
| LifeStance Health Grp Inc | Kenneth A. Burdick | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.59 per share. | 06 Mar 2025 | 166,762 | 3,404,718 | - | 7.6 | 1,265,724 | Common Stock |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 166,667 | 166,667 | - | - | Restricted Stock Units | |
| Cerus Corp | William M. Greenman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 165,742 | 4,370,742 (2%) | 0% | 0 | Common Stock | |
| Shell PLC (ADR) (Representing - Ordinary Shares) | Sinead Gorman | Executive Director,Chief Financial Officer | 06 Mar 2025 | 162,056 | 244,999 (0%) | 0% | 0 | Ords | ||
| Shell PLC (ADR) (Representing - Ordinary Shares) | Wael Sawan | Executive Director,Chief Executive Officer | 06 Mar 2025 | 151,531 | 447,543 (0%) | 0% | 0 | Ords | ||
| Walmart | Christopher Nicholas | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 148,838 | 497,195 (0%) | 0% | 0 | Common | |
| Emergent Biosolutions Inc | Richard S. Lindahl | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 146,888 | 299,225 (0%) | 0% | 0 | Common Stock | |
| Fluor Corp | David E. Constable | Director, CHAIRMAN AND CEO | 06 Mar 2025 | 143,756 | 911,427 (0%) | 0% | 36.6 | 5,258,594 | Common Stock | |
| Indie Semiconductor Inc (Class A) | Donald McClymont | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 143,250 | 312,289 | - | 0 | Class A Common Stock | |
| Indie Semiconductor Inc (Class A) | Donald McClymont | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 143,250 | 143,250 | - | - | Performance-based Restricted Stock Units | |
| Aris Water Soln Inc (Class A) | Amanda M. Brock | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 136,498 | 546,299 | - | 0 | Class A Common Stock | |
| Akari Therapeutics PLC (ADR) | Abizer Gaslightwala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 133,928 | 133,928 | - | - | Series A Warrants (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Abizer Gaslightwala | Director | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 06 Mar 2025 | 133,928 | 181,428 (0%) | 0% | 1.1 | 149,999 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics PLC (ADR) | Abizer Gaslightwala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 133,928 | 133,928 | - | - | Series B Warrants (Right to Buy) | |
| Viatris | Corinne Le Goff | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 132,493 | 132,493 | - | - | Restricted Stock Units | |
| 4D Molecular Therapeutics Inc | Uneek Mehra | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| LegalZoom.com Inc | Charles C. Thomas | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 128,712 | 128,712 | - | 0 | Common Stock | |
| CCC Intelligent Soln Holdings Inc | John Goodson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 128,343 | 128,343 | - | - | Restricted Stock Unit | |
| Sera Prognostics Inc (Class A) | Zhenya Lindgardt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 126,920 | 906,379 | - | 0 | Class A Common Stock | |
| Viatris | Theodora Mistras | Chief Financial Officer | 06 Mar 2025 | 125,132 | 125,132 | - | - | Restricted Stock Units | ||
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 124,644 | 941,939 | - | 0 | Common Stock | |
| Baxter International | Heather L. Knight | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 118,934 | 118,934 | - | - | Stock Option (Right to Buy) | |
| Global Business Travel Grp Inc (Class A) | Evan Konwiser | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 117,957 | 790,805 | - | 0 | Class A Common Stock | |
| Halliburton | Jefferey A. Miller | Director, Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.01 per share. | 06 Mar 2025 | 117,445 | 1,017,696 (0%) | 0% | 25.0 | 2,937,299 | Common Stock |
| LifeStance Health Grp Inc | Pablo Pantaleoni | Chief Digital Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 117,386 | 1,417,313 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | Pablo Pantaleoni | Chief Digital Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 117,386 | 859,228 | - | 0 | Common Stock | |
| Burford Cap Ltd | Jonathan Molot | Chief Investment Officer | 06 Mar 2025 | 115,787 | 1,950,930 | - | - | Phantom RSUs | ||
| Artivion Inc | James Patrick Mackin | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 115,701 | 878,107 (2%) | 0% | 0 | Common Stock | |
| Burford Cap Ltd | Christopher P. Bogart | Director, Chief Executive Officer | 06 Mar 2025 | 114,983 | 1,877,773 | - | - | Phantom RSUs | ||
| LifeStance Health Grp Inc | Ryan Pardo | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 114,213 | 860,652 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | Kenneth A. Burdick | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.59 per share. | 06 Mar 2025 | 111,430 | 3,147,690 | - | 7.6 | 845,754 | Common Stock |
| Walmart | Donna Morris | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 107,590 | 466,748 (0%) | 0% | 0 | Common | |
| Aware Inc | Brian J. Krause | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 105,000 | 105,000 | - | - | Stock Option (right to buy) | |
| Walmart | Daniel J. Bartlett | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 102,697 | 526,293 (0%) | 0% | 0 | Common Stock | |
| Walmart | Rachel Brand | Executive Vice President | 06 Mar 2025 | 102,697 | 297,153 (0%) | 0% | 0 | Common | ||
| Amylyx Pharma Inc | James M. Frates | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 102,630 | 102,630 | - | - | Stock Option (right to buy) | |
| Amylyx Pharma Inc | Camille L. Bedrosian | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 102,630 | 102,630 | - | - | Stock Option (Right to Buy) | |
| D-Wave Quantum Inc | Diane Nguyen | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 101,721 | 547,092 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Baxter International | Alok Sonig | EVP,Group President,Pharma | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 99,905 | 99,905 | - | - | Stock Option (Right to Buy) | |
| LifeStance Health Grp Inc | Pablo Pantaleoni | Chief Digital Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 98,578 | 1,524,605 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | Pablo Pantaleoni | Chief Digital Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 98,578 | 966,520 | - | 0 | Common Stock | |
| Baxter International | Joel T. Grade | EVP and CFO | 06 Mar 2025 | 98,478 | 98,478 | - | - | Stock Option (Right to Buy) | ||
| Semtech Corp | Hong Q. Hou | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 97,550 | 97,550 | - | - | Restricted Stock Unit | |
| LifeStance Health Grp Inc | Ryan Pardo | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 95,875 | 965,546 | - | 0 | Common Stock | |
| Amylyx Pharma Inc | Gina M. Mazzariello | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 95,777 | 95,777 | - | - | Stock Option (right to buy) | |
| Solventum | Bryan C. Hanson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 95,723 | 95,723 | - | - | Restricted Stock Units | |
| LifeStance Health Grp Inc | Kenneth A. Burdick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 95,178 | 3,029,550 | - | 0 | Common Stock | |
| Viatris | Brian Roman | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 93,849 | 93,849 | - | - | Restricted Stock Units | |
| 4D Molecular Therapeutics Inc | Robert Young Kim | Chief Medical Officer | 06 Mar 2025 | 92,300 | 92,300 | - | - | Stock Option (Right to Buy) | ||
| Abbott | Lisa D. Earnhardt | EVP AND GROUP PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 80.98 per share. | 06 Mar 2025 | 91,167 | 163,095 (0%) | 0% | 81.0 | 7,382,704 | Common shares without par value |
| Abbott | Lisa D. Earnhardt | EVP AND GROUP PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 91,167 | 200 | - | - | Option (right to buy) | |
| Abbott | Lisa D. Earnhardt | EVP AND GROUP PRESIDENT | Sale of securities on an exchange or to another person at price $ 133.82 per share. | 06 Mar 2025 | 91,167 | 71,928 (0%) | 0% | 133.8 | 12,199,968 | Common shares without par value |
| Veracyte Inc | Marc A. Stapley | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 90,601 | 358,636 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp | Vivek K. Jayaraman | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 90,486 | 1,541,314 (0%) | 0% | 0 | Common Stock | |
| Astrazeneca plc | Pascal Soriot | Executive Director,Chief Executive Officer | 06 Mar 2025 | 89,962 | 377,428 (0%) | 0% | 0 | Ords 0.25p | ||
| Baxter International | Reazur Rasul | EVP,Group Pres,Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 87,417 | 87,417 | - | - | Stock Option (Right to Buy) | |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.45 per share. | 06 Mar 2025 | 87,007 | 2,283,851 | - | 40.5 | 3,519,598 | Ordinary Shares |
| Medpace Holdings Inc | August J. Troendle | Director, CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 84,770 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Medpace Holdings Inc | August J. Troendle | Director, CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 107.93 per share. | 06 Mar 2025 | 84,770 | 1,011,102 (2%) | 0% | 107.9 | 9,149,226 | Common Stock |
| Archrock Inc | D. Bradley Childers | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.70 per share. | 06 Mar 2025 | 84,221 | 2,246,506 (1%) | 0% | 29.7 | 2,501,364 | Common Stock |
| Aris Water Soln Inc (Class A) | William A. Zartler | Director, Founder and Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 83,725 | 584,270 | - | 0 | Class A Common Stock | |
| Viatris | Paul B. Campbell | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 82,808 | 82,808 | - | - | Restricted Stock Units | |
| Stardust Power Inc | Udaychandra Devasper | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 82,457 | 824,568 | - | - | Restricted Stock Unit | |
| Stardust Power Inc | Udaychandra Devasper | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 82,457 | 243,783 | - | - | Common Stock | |
| Stardust Power Inc | Udaychandra Devasper | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 82,456 | 907,025 | - | - | Restricted Stock Unit | |
| Stardust Power Inc | Udaychandra Devasper | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 82,456 | 200,269 | - | - | Common Stock | |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 80,906 | 846,980 | - | 0 | Common Stock | |
| Cerus Corp | Kevin D. Green | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 80,540 | 966,902 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Kenneth Duda | Director, CTO and SVP Software Eng. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 80,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Arista Networks | Kenneth Duda | Director, CTO and SVP Software Eng. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 06 Mar 2025 | 80,000 | 92,976 (0%) | 0% | 4.0 | 322,304 | Common Stock |
| TaskUs Inc (Class A) | Jarrod Johnson | Chief Customer Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 78,585 | 78,585 | - | - | Restricted Stock Units | |
| TaskUs Inc (Class A) | Balaji Sekar | Chief Financial Officer | 06 Mar 2025 | 78,585 | 78,585 | - | - | Restricted Stock Units | ||
| TaskUs Inc (Class A) | Stephan Daoust | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 78,585 | 78,585 | - | - | Restricted Stock Units | |
| 4D Molecular Therapeutics Inc | Scott Bizily | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 78,500 | 78,500 | - | - | Stock Option (Right to Buy) | |
| Senti Biosciences Inc | Kanya Rajangam | Pres. & Chief Med. & Dev. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 78,363 | 86,984 | - | 0 | Common Stock | |
| Herzfeld Caribbean Basin Fund Inc | Erik M. Herzfeld | President, Portfolio Manager | Purchase of securities on an exchange or from another person at price $ 2.59 per share. | 06 Mar 2025 | 77,976 | 488,931 (7%) | 1% | 2.6 | 202,207 | Common stock |
| NCR Atleos Corp | R. Andrew Wamser | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 25.76 per share. | 06 Mar 2025 | 77,640 | 99,715 | - | 25.8 | 2,000,006 | Common Stock |
| LifeStance Health Grp Inc | Ann Varanakis | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 76,142 | 339,149 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | Lisa K. Miller | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 76,142 | 365,086 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | Ann Varanakis | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 76,142 | 339,149 | - | 0 | Common Stock | |
| Artivion Inc | James Patrick Mackin | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.55 per share. | 06 Mar 2025 | 75,615 | 935,983 (2%) | 0% | 21.5 | 1,629,503 | Common Stock |
| Artivion Inc | James Patrick Mackin | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 75,615 | 0 | - | - | Stock Options (Right to buy) | |
| Clover Health Investments Corp (Class A) | Brady Patrick Priest | CEO of Home Care | Sale of securities on an exchange or to another person at price $ 3.68 per share. | 06 Mar 2025 | 75,000 | 2,418,151 | - | 3.7 | 276,000 | Class A Common Stock |
| Medpace Holdings Inc | August J. Troendle | Director, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 73,443 | 73,443 | - | - | Employee Stock Option (Right to Buy) | |
| Chewy Inc (Class A) | Satish Mehta | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 35.60 per share. | 06 Mar 2025 | 71,365 | 262,853 (0%) | 0% | 35.6 | 2,540,594 | Class A Common Stock |
| Archrock Inc | Douglas S. Aron | SR VICE PRESIDENT, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 71,342 | 618,036 (0%) | 0% | 0 | Common Stock | |
| Archrock Inc | Douglas S. Aron | SR VICE PRESIDENT, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 71,342 | 0 | - | - | Performance Share Units | |
| Artivion Inc | James Patrick Mackin | President & CEO | Sale of securities on an exchange or to another person at price $ 24.76 per share. | 06 Mar 2025 | 70,700 | 865,283 (2%) | 0% | 24.8 | 1,750,843 | Common Stock |
| Alphatec Holdings Inc | Patrick S. Miles | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.44 per share. | 06 Mar 2025 | 70,097 | 5,870,294 (9%) | 0% | 11.4 | 801,910 | Common Stock |
| Cerus Corp | Chrystal Jensen | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 69,577 | 859,775 (0%) | 0% | 0 | Common Stock | |
| Amylyx Pharma Inc | James M. Frates | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 68,420 | 301,884 | - | 0 | Common Stock | |
| Amylyx Pharma Inc | Camille L. Bedrosian | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 68,420 | 206,800 | - | 0 | Common Stock | |
| AMBAC Fin Grp Inc | David Trick | Exec VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 66,577 | 159,799 | - | - | Deferred Share Units | |
| Cerus Corp | Richard J. Benjamin | Chief Medical Officer | 06 Mar 2025 | 66,565 | 760,938 (0%) | 0% | 0 | Common Stock | ||
| Indie Semiconductor Inc (Class A) | Donald McClymont | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.90 per share. | 06 Mar 2025 | 65,754 | 246,535 | - | 2.9 | 190,687 | Class A Common Stock |
| Kontoor Brands Inc | Scott H. Baxter | Director, Chair, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Mar 2025 | 65,003 | 289,339 (0%) | 0% | 0 | Common Stock | |
| Kontoor Brands Inc | Scott H. Baxter | Director, Chair, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Mar 2025 | 65,003 | 172,130 (0%) | 0% | 0 | Common Stock | |
| Amylyx Pharma Inc | Gina M. Mazzariello | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 63,851 | 197,161 | - | 0 | Common Stock | |
| Core Scientific Inc - Ordinary Shares - New | Jordan Levy | Director | 06 Mar 2025 | 62,500 | 306,887 | - | 8.0 | 500,506 | Common Stock | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 249,613 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 176,656 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Paul Williams | SVP, Products Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 210,114 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Paul Williams | SVP, Products Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 86,335 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 109,975 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 214,711 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Jessica Perl | SVP, General Counsel, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 68,387 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Jessica Perl | SVP, General Counsel, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 95,945 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Simon C. Lowry | SVP, R&D, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 102,999 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Simon C. Lowry | SVP, R&D, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 91,982 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Bill Hartzel | SVP, Bioservices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 109,683 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp | William M. Greenman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.50 per share. | 06 Mar 2025 | 60,984 | 4,309,758 (2%) | 0% | 1.5 | 91,354 | Common Stock |
| Q2 Holdings Inc | Matthew P. Flake | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 60,887 | 514,736 (1%) | 0% | 0 | Common Stock | |
| AbCellera Biologics Inc | John S. Montalbano | Director | Purchase of securities on an exchange or from another person at price $ 2.34 per share. | 06 Mar 2025 | 60,000 | 146,000 | - | 2.3 | 140,568 | Common Shares |
| LifeMD Inc | Stefan Galluppi | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 60,000 | 105,449 | - | 0 | Common Shares | |
| AMBAC Fin Grp Inc | R. Sharon Smith | Exec VP & Chief Strategy Offr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 59,408 | 140,174 | - | - | Deferred Share Units | |
| Baxter International | David S. Rosenbloom | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 58,873 | 58,873 | - | - | Stock Option (Right to Buy) | |
| LTC Properties Inc | Wendy L. Simpson | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 34.89 per share. | 06 Mar 2025 | 58,812 | 409,990 (1%) | 0% | 34.9 | 2,051,951 | Common Stock |
| Stem Inc (Class A) | Saul R. Laureles | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 58,334 | 262,148 | - | 0 | Common Stock, Par Value $0.0001 Per Share | |
| Stem Inc (Class A) | Saul R. Laureles | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 58,334 | 448,996 | - | - | Restricted Stock Unit | |
| LifeStance Health Grp Inc | Ujjwal Ramtekkar | Chief Medical Officer | 06 Mar 2025 | 57,107 | 119,520 | - | 0 | Common Stock | ||
| Q2 Holdings Inc | Matthew P. Flake | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 78.28 per share. | 06 Mar 2025 | 56,799 | 453,849 (0%) | 0% | 78.3 | 4,446,226 | Common Stock |
| Adma Biologics Inc | Adam S. Grossman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.91 per share. | 06 Mar 2025 | 56,438 | 2,097,363 (2%) | 0% | 16.9 | 954,367 | Common Stock |
| Evolent Health Inc (Class A) | Seth Blackley | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 9.01 per share. | 06 Mar 2025 | 55,225 | 762,217 (0%) | 0% | 9.0 | 497,577 | Class A Common Stock |
| AMBAC Fin Grp Inc | Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 53,999 | 129,146 | - | - | Deferred Share Units | |
| LifeStance Health Grp Inc | Kenneth A. Burdick | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.88 per share. | 06 Mar 2025 | 53,602 | 2,975,948 | - | 7.9 | 422,384 | Common Stock |
| Sana biotech Inc | Bernard J. Cassidy | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 53,333 | 53,333 | - | - | Restricted Stock Units | |
| Clover Health Investments Corp (Class A) | Karen M. Soares | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 3.80 per share. | 06 Mar 2025 | 52,500 | 1,299,663 | - | 3.8 | 199,500 | Class A Common Stock |
| Baxter International | Jeanne K. Mason | EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 52,331 | 52,331 | - | - | Stock Option (Right to Buy) | |
| TaskUs Inc (Class A) | Claudia Walsh | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 51,080 | 51,080 | - | - | Restricted Stock Units | |
| Domo Inc (Class B) | Ryan Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 50,638 | 50,638 (0%) | 0% | 0 | Class B Common Stock | |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 50,000 | 150,000 | - | - | Restricted Stock Units | |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 50,000 | 7,889,750 | - | 0 | Common Stock | |
| Skyward Specialty Insurance Grp Inc | Andrew Robinson | Director, CHAIRMAN & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 50,000 | 102,355 | - | - | Common Stock | |
| Skyward Specialty Insurance Grp Inc | Andrew Robinson | Director, CHAIRMAN & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 50,000 | 50,000 | - | - | 2023 IPO RSU Grant (3-Year) | |
| Stepan Co. | F. Quinn Stepan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 49,154 | 45,544 | - | - | Share Units | |
| Asure Software Inc | Patrick F. Goepel | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 48,668 | 1,270,665 (8%) | 0% | 0 | Asure Software, Inc. Common Stock ($0.01 par value) | |
| Artivion Inc | Lance A. Berry | Executive VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 48,100 | 158,340 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 47,407 | 297,283 (1%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 47,407 | 47,407 | - | - | Restricted Stock Units | |
| AMBAC Fin Grp Inc | David Barranco | Senior Managing Director | 06 Mar 2025 | 45,907 | 91,710 | - | - | Deferred Share Units | ||
| Perdoceo Education Corporation | Todd S. Nelson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 45,880 | 699,457 (0%) | 0% | 0 | Common Stock | |
| Perdoceo Education Corporation | Todd S. Nelson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 45,880 | 653,577 (0%) | 0% | 0 | Common Stock | |
| Fortrea Holdings Inc | Jill McConnell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 45,850 | 121,370 | - | - | Restricted Stock Unit | |
| Loews | Jonathan M. Tisch | DIRECTOR EMERITUS | 06 Mar 2025 | 45,353 | 6,814,823 (2%) | 0% | 85.0 | 3,856,819 | Common Stock | |
| Loews | Jonathan M. Tisch | DIRECTOR EMERITUS | 06 Mar 2025 | 45,353 | 6,860,176 (2%) | 0% | 85.0 | 3,856,819 | Common Stock | |
| Stifel Fin Corp | Ronald J. Kruszewski | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 45,108 | 177,889 | - | - | Phantom Stock Units | |
| Tredegar Corp | D. Andrew Edwards | See Remarks | 06 Mar 2025 | 44,832 | 198,355 (0%) | 0% | 0 | Tredegar Common Stock | ||
| Akari Therapeutics PLC (ADR) | Robert B. Bazemore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 44,642 | 44,642 | - | - | Series A Warrants (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Robert B. Bazemore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 44,642 | 44,642 | - | - | Series B Warrants (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Robert B. Bazemore | Director | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 06 Mar 2025 | 44,642 | 44,642 (0%) | 0% | 1.1 | 49,999 | American Depositary Shares representing Ordinary Shares |
| Heritage Global Inc | Ross Dove | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 44,355 | 2,347,011 | - | 0 | Common Stock | |
| Warner Bros. (Class A) | Bruce L. Campbell | Chief Rev & Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.70 per share. | 06 Mar 2025 | 43,577 | 1,131,298 (0%) | 0% | 10.7 | 466,274 | Series A Common Stock |
| Warner Bros. (Class A) | Gunnar Wiedenfels | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.70 per share. | 06 Mar 2025 | 43,577 | 1,388,830 (0%) | 0% | 10.7 | 466,274 | Series A Common Stock |
| Warner Bros. (Class A) | Jean-Briac Perrette | Pres.&CEO, Global Streaming | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.70 per share. | 06 Mar 2025 | 43,346 | 1,499,334 (0%) | 0% | 10.7 | 463,802 | Series A Common Stock |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.59 per share. | 06 Mar 2025 | 42,816 | 899,123 | - | 7.6 | 324,973 | Common Stock |
| Archrock Inc | Stephanie Hildebrandt | SVP, GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 42,806 | 419,570 (0%) | 0% | 0 | Common Stock | |
| Archrock Inc | Stephanie Hildebrandt | SVP, GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 42,806 | 0 | - | - | Performance Share Units | |
| LifeStance Health Grp Inc | Pablo Pantaleoni | Chief Digital Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 42,765 | 1,440,634 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | Pablo Pantaleoni | Chief Digital Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 42,765 | 882,549 | - | 0 | Common Stock | |
| Aris Water Soln Inc (Class A) | Stephan E. Tompsett | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 42,414 | 160,509 | - | 0 | Class A Common Stock | |
| CCC Intelligent Soln Holdings Inc | Brian Herb | See Remarks | 06 Mar 2025 | 42,230 | 84,460 | - | - | Restricted Stock Unit | ||
| CCC Intelligent Soln Holdings Inc | Brian Herb | See Remarks | 06 Mar 2025 | 42,230 | 341,197 | - | 0 | Common Stock | ||
| Fortrea Holdings Inc | Mark A. Morais | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 41,898 | 117,532 | - | - | Restricted Stock Unit | |
| LifeStance Health Grp Inc | Ryan Pardo | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 41,609 | 883,342 | - | 0 | Common Stock | |
| Halliburton | Mark J. Richard | President - Western Hemisphere | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.01 per share. | 06 Mar 2025 | 41,455 | 601,278 (0%) | 0% | 25.0 | 1,036,790 | Common Stock |
| Yelp Inc | Jeremy Stoppelman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 39,733 | 821,160 (1%) | 0% | 0 | Common Stock | |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 19.55 per share. | 06 Mar 2025 | 39,477 | 900,249 | - | 19.6 | 771,815 | Class A Common Stock |
| TaskUs Inc (Class A) | Jaspar Weir | Director, President, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 39,292 | 39,292 | - | - | Restricted Stock Units | |
| Stardust Power Inc | Udaychandra Devasper | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.68 per share. | 06 Mar 2025 | 38,943 | 161,326 | - | 0.7 | 26,532 | Common Stock |
| Stardust Power Inc | Udaychandra Devasper | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.68 per share. | 06 Mar 2025 | 38,856 | 204,927 | - | 0.7 | 26,379 | Common Stock |
| Asure Software Inc | Eyal Goldstein | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 38,239 | 333,334 (2%) | 0% | 0 | Asure Software, Inc. Common Stock ($0.01 par value) | |
| CCC Intelligent Soln Holdings Inc | Rodney Christo | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 37,434 | 37,434 | - | - | Restricted Stock Unit | |
| Medpace Holdings Inc | August J. Troendle | Director, CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.74 per share. | 06 Mar 2025 | 37,417 | 692,073 (1%) | 0% | 54.7 | 2,048,207 | Common Stock |
| Medpace Holdings Inc | August J. Troendle | Director, CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 37,417 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Teradata Corp | Steve McMillan | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 06 Mar 2025 | 36,742 | 559,125 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | John Leite | Chief Commercial Officer-CLIA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 36,240 | 107,660 (0%) | 0% | 0 | Common Stock | |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.14 per share. | 06 Mar 2025 | 36,207 | 2,247,644 | - | 41.1 | 1,489,527 | Ordinary Shares |
| Aris Water Soln Inc (Class A) | Robert W. Hunt | Chief Legal Officer and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 35,771 | 113,329 | - | 0 | Class A Common Stock | |
| Baxter International | Heather L. Knight | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 35,674 | 177,362 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Aris Water Soln Inc (Class A) | D Dylan Van Brunt | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 35,411 | 117,961 | - | 0 | Class A Common Stock | |
| Warner Bros. (Class A) | Gerhard Zeiler | President, International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.70 per share. | 06 Mar 2025 | 35,211 | 1,000,390 (0%) | 0% | 10.7 | 376,758 | Series A Common Stock |
| Cerus Corp | Vivek K. Jayaraman | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.50 per share. | 06 Mar 2025 | 33,999 | 1,507,315 (0%) | 0% | 1.5 | 50,931 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Brian Herb | See Remarks | 06 Mar 2025 | 33,755 | 101,267 | - | - | Restricted Stock Unit | ||
| CCC Intelligent Soln Holdings Inc | Brian Herb | See Remarks | 06 Mar 2025 | 33,755 | 374,952 | - | 0 | Common Stock | ||
| Tredegar Corp | Kevin C. Donnelly | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 33,748 | 154,963 (0%) | 0% | 0 | Tredegar Common Stock | |
| Alphatec Holdings Inc | David P. Sponsel | EVP, SALES | Sale of securities on an exchange or to another person at price $ 10.83 per share. | 06 Mar 2025 | 33,732 | 668,977 (1%) | 0% | 10.8 | 365,318 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Brian Herb | See Remarks | 06 Mar 2025 | 33,662 | 341,290 | - | 9.4 | 314,740 | Common Stock | |
| Baxter International | James Borzi | EVP,Chief Supply Chain Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 33,302 | 33,302 | - | - | Stock Option (Right to Buy) | |
| Halliburton | Lawrence J. Pope | EVP Administration & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.01 per share. | 06 Mar 2025 | 33,206 | 489,741 (0%) | 0% | 25.0 | 830,482 | Common Stock |
| Halliburton | Eric J. Carre | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.01 per share. | 06 Mar 2025 | 33,206 | 178,280 (0%) | 0% | 25.0 | 830,482 | Common Stock |
| Halliburton | Van H. Beckwith | EVP, Secretary and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.01 per share. | 06 Mar 2025 | 33,206 | 348,128 (0%) | 0% | 25.0 | 830,482 | Common Stock |
| DoubleVerify Holdings Inc | Mark S. Zagorski | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 33,078 | 33,078 | - | - | Performance Stock Units | |
| Radian Grp Inc | Sumita Pandit | Sr. EVP - CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 32,823 | 32,823 (0%) | 0% | 0 | Common Stock | |
| Radian Grp Inc | Sumita Pandit | Sr. EVP - CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 32,823 | 0 | - | - | Restricted Stock Units - Time Vested Award | |
| Walmart | David Chojnowski | Senior Vice President | 06 Mar 2025 | 32,275 | 110,153 (0%) | 0% | 0 | Common Stock | ||
| Arista Networks | Kenneth Duda | Director, CTO and SVP Software Eng. | Sale of securities on an exchange or to another person at price $ 83.94 per share. | 06 Mar 2025 | 32,113 | 60,863 (0%) | 0% | 83.9 | 2,695,652 | Common Stock |
| LifeStance Health Grp Inc | Ann Varanakis | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 32,052 | 388,761 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | Ann Varanakis | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 32,052 | 385,036 | - | 0 | Common Stock | |
| CCC Intelligent Soln Holdings Inc | John Goodson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 31,673 | 63,345 | - | - | Restricted Stock Unit | |
| CCC Intelligent Soln Holdings Inc | John Goodson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 31,673 | 175,644 | - | 0 | Common Stock | |
| LTC Properties Inc | Wendy L. Simpson | Director, EXECUTIVE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.89 per share. | 06 Mar 2025 | 31,671 | 378,319 (0%) | 0% | 34.9 | 1,105,001 | Common Stock |
| NextTrip Inc | Jacob Brunsberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 31,250 | 31,250 | - | - | Stock Option (right to buy) | |
| Cerus Corp | Kevin D. Green | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.50 per share. | 06 Mar 2025 | 31,148 | 935,754 (0%) | 0% | 1.5 | 46,660 | Common Stock |
| Archrock Inc | Jason G. Ingersoll | SENIOR VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 30,914 | 330,112 (0%) | 0% | 0 | Common Stock | |
| Archrock Inc | Jason G. Ingersoll | SENIOR VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 30,914 | 0 | - | - | Performance Share Units | |
| Archrock Inc | Eric W. Thode | SR VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 30,914 | 246,974 (0%) | 0% | 0 | Common Stock | |
| Archrock Inc | Eric W. Thode | SR VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 30,914 | 0 | - | - | Performance Share Units | |
| TaskUs Inc (Class A) | Bryce Maddock | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 30,588 | 31,515 | - | - | Restricted Stock Units | |
| TaskUs Inc (Class A) | Bryce Maddock | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 30,588 | 925,026 | - | - | Class A Common Stock | |
| Q2 Holdings Inc | Matthew P. Flake | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 30,444 | 545,180 (1%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Matthew P. Flake | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 30,443 | 575,623 (1%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Jonathan A. Price | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 30,443 | 209,534 (0%) | 0% | 0 | Common Stock | |
| Q2 Holdings Inc | Kirk L. Coleman | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 30,443 | 303,404 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Rebecca Chambers | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 30,200 | 143,899 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 30,200 | 100,508 (0%) | 0% | 0 | Common Stock | |
| Acadia Realty Trust | Jason Blacksberg | EVP and Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 22.81 per share. | 06 Mar 2025 | 30,000 | 0 (0%) | 0% | 22.8 | 684,300 | Common Shares of Beneficial Interest |
| Acadia Realty Trust | Jason Blacksberg | EVP and Chief Legal Officer | 06 Mar 2025 | 30,000 | 30,000 (0%) | 0% | 0 | Common Shares of Beneficial Interest | ||
| Acadia Realty Trust | Jason Blacksberg | EVP and Chief Legal Officer | 06 Mar 2025 | 30,000 | 302,413 | - | - | LTIP Units | ||
| Baxter International | Alok Sonig | EVP,Group President,Pharma | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 29,966 | 130,298 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Sera Prognostics Inc (Class A) | Zhenya Lindgardt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.12 per share. | 06 Mar 2025 | 29,722 | 876,657 | - | 4.1 | 122,455 | Class A Common Stock |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.59 per share. | 06 Mar 2025 | 29,685 | 817,295 | - | 7.6 | 225,309 | Common Stock |
| Baxter International | Joel T. Grade | EVP and CFO | 06 Mar 2025 | 29,538 | 118,434 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Adma Biologics Inc | Adam S. Grossman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.02 per share. | 06 Mar 2025 | 29,513 | 2,067,850 (2%) | 0% | 17.0 | 502,311 | Common Stock |
| Semtech Corp | Asaf Silberstein | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 29,265 | 29,265 | - | - | Restricted Stock Unit | |
| Stem Inc (Class A) | Matthew Tappin | President, Software Division | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 29,167 | 69,740 | - | 0 | Common Stock, Par Value $0.0001 Per Share | |
| Stem Inc (Class A) | Matthew Tappin | President, Software Division | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 29,167 | 399,559 | - | - | Restricted Stock Unit | |
| LifeStance Health Grp Inc | Pablo Pantaleoni | Chief Digital Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.59 per share. | 06 Mar 2025 | 28,947 | 1,495,658 | - | 7.6 | 219,708 | Common Stock |
| LifeStance Health Grp Inc | Pablo Pantaleoni | Chief Digital Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.59 per share. | 06 Mar 2025 | 28,947 | 937,573 | - | 7.6 | 219,708 | Common Stock |
| LTC Properties Inc | Clint B. Malin | CO-PRESIDENT, CO-CEO & CIO | Grant, award, or other acquisition of securities at price $ 34.89 per share. | 06 Mar 2025 | 28,700 | 208,244 (0%) | 0% | 34.9 | 1,001,343 | Common Stock |
| LTC Properties Inc | Pamela J. Shelley-Kessler | CO-PRESIDENT AND CO-CEO | Grant, award, or other acquisition of securities at price $ 34.89 per share. | 06 Mar 2025 | 28,700 | 212,845 (0%) | 0% | 34.9 | 1,001,343 | Common Stock |
| Semtech Corp | Mark Lin | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 28,181 | 28,181 | - | - | Restricted Stock Unit | |
| LifeStance Health Grp Inc | Ryan Pardo | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.59 per share. | 06 Mar 2025 | 28,154 | 937,392 | - | 7.6 | 213,689 | Common Stock |
| Archrock Inc | Douglas S. Aron | SR VICE PRESIDENT, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.70 per share. | 06 Mar 2025 | 28,074 | 589,962 (0%) | 0% | 29.7 | 833,798 | Common Stock |
| Asure Software Inc | John F. Pence | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 27,810 | 217,810 (1%) | 0% | 0 | Asure Software, Inc. Common Stock ($0.01 par value) | |
| Alphatec Holdings Inc | Tyson Marshall | GENERAL COUNSEL & CORP. SEC. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.44 per share. | 06 Mar 2025 | 27,805 | 450,953 (0%) | 0% | 11.4 | 318,089 | Common Stock |
| LifeStance Health Grp Inc | Ann Varanakis | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 27,740 | 360,434 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | Ann Varanakis | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 27,740 | 360,434 | - | 0 | Common Stock | |
| Cerus Corp | Chrystal Jensen | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 1.50 per share. | 06 Mar 2025 | 27,457 | 832,318 (0%) | 0% | 1.5 | 41,131 | Common Stock |
| Perdoceo Education Corporation | Dennis H. Chookaszian | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 26,664 | 0 | - | - | Non-Qualified Option (right to buy) | |
| Perdoceo Education Corporation | Dennis H. Chookaszian | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.93 per share. | 06 Mar 2025 | 26,664 | 112,299 (0%) | 0% | 3.9 | 104,790 | Common Stock |
| Arista Networks | Kenneth Duda | Director, CTO and SVP Software Eng. | Sale of securities on an exchange or to another person at price $ 85.92 per share. | 06 Mar 2025 | 26,606 | 15,261 (0%) | 0% | 85.9 | 2,285,929 | Common Stock |
| Reinsurance Grp Of America Inc | Tony Kin Shun Cheng | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 26,532 | 26,532 | - | - | Stock Appreciation Right (right to purchase) 2025 | |
| Pediatrix Medical Grp Inc | Mary Ann E. Moore | EVP, GC, Chief Admin Off & Sec | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Mar 2025 | 26,497 | 100,338 (0%) | 0% | 0 | Common Stock | |
| Solventum | Wayde D. McMillan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 26,407 | 26,407 | - | - | Restricted Stock Units | |
| Baxter International | Reazur Rasul | EVP,Group Pres,Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 26,220 | 124,614 (0%) | 0% | 0 | Common Stock, $1 par value | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.19 per share. | 06 Mar 2025 | 26,160 | 271,123 (1%) | 0% | 13.2 | 345,050 | Common Stock |
| Cerus Corp | Richard J. Benjamin | Chief Medical Officer | 06 Mar 2025 | 26,139 | 734,799 (0%) | 0% | 1.5 | 39,156 | Common Stock | |
| Arista Networks | Kenneth Duda | Director, CTO and SVP Software Eng. | Sale of securities on an exchange or to another person at price $ 83.94 per share. | 06 Mar 2025 | 25,691 | 1,421,477 (1%) | 0% | 83.9 | 2,156,572 | Common Stock |
| Artivion Inc | John E. Davis | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 25,654 | 210,586 (0%) | 0% | 0 | Common Stock | |
| Journey Medical Corp | Claude Maraoui | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 5.04 per share. | 06 Mar 2025 | 25,551 | 2,067,323 | - | 5.0 | 128,777 | Common Stock, $0.0001 par value |
| Artivion Inc | Jean F. Holloway | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 25,493 | 198,236 (0%) | 0% | 0 | Common Stock | |
| CCC Intelligent Soln Holdings Inc | John Goodson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 25,316 | 200,960 | - | 0 | Common Stock | |
| CCC Intelligent Soln Holdings Inc | John Goodson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 25,316 | 75,950 | - | - | Restricted Stock Unit | |
| Brookdale Senior Living Inc | Chad C. White | EVP, General Counsel & Secy | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Mar 2025 | 25,000 | 518,023 (0%) | 0% | 0 | Common Stock | |
| Indie Semiconductor Inc (Class A) | Michael Wittmann | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 25,000 | 80,582 | - | 0 | Class A Common Stock | |
| Indie Semiconductor Inc (Class A) | Michael Wittmann | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 25,000 | 75,000 | - | - | Restricted Stock Units | |
| Indie Semiconductor Inc (Class A) | Michael Wittmann | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 25,000 | 25,000 | - | - | Performance-based Restricted Stock Units | |
| Loews | Jonathan M. Tisch | DIRECTOR EMERITUS | 06 Mar 2025 | 25,000 | 6,905,529 (2%) | 0% | 85.3 | 2,133,250 | Common Stock | |
| Loews | Jonathan M. Tisch | DIRECTOR EMERITUS | 06 Mar 2025 | 25,000 | 6,930,529 (2%) | 0% | 85.3 | 2,133,250 | Common Stock | |
| Loews | Jonathan M. Tisch | DIRECTOR EMERITUS | 06 Mar 2025 | 25,000 | 6,955,529 (2%) | 0% | 84.8 | 2,119,500 | Common Stock | |
| Loews | Jonathan M. Tisch | DIRECTOR EMERITUS | 06 Mar 2025 | 25,000 | 6,980,529 (2%) | 0% | 84.8 | 2,119,500 | Common Stock | |
| CCC Intelligent Soln Holdings Inc | John Goodson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.35 per share. | 06 Mar 2025 | 24,906 | 176,054 | - | 9.3 | 232,871 | Common Stock |
| GXO Logistics Inc | Malcolm Wilson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 24,809 | 24,809 | - | - | Restricted Stock Units | |
| CCC Intelligent Soln Holdings Inc | Marc Fredman | SVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 24,634 | 49,269 | - | - | Restricted Stock Unit | |
| CCC Intelligent Soln Holdings Inc | Marc Fredman | SVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 24,634 | 258,891 | - | 0 | Common Stock | |
| Veracyte Inc | Phillip G. Febbo | Chief Scientific & Med Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 24,160 | 106,700 (0%) | 0% | 0 | Common Stock | |
| Ziff Davis Inc | Vivek Shah | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 23,674 | 47,349 | - | - | Restricted Stock Units | |
| Ziff Davis Inc | Vivek Shah | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 23,674 | 305,737 (0%) | 0% | 0 | Common Stock $0.01 Par Value | |
| Viatris | Elisha W. Finney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | |
| Viatris | Harry A. Korman | Director | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | ||
| Viatris | James M. Kilts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | |
| Viatris | Rajiv Malik | Director | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | ||
| Viatris | Wyllie Don Cornwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | |
| Viatris | Mark W. Parrish | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | |
| Viatris | Melina E. Higgins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | |
| Viatris | Dillon JoEllen Lyons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | |
| Viatris | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | |
| Viatris | Richard A. Mark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | |
| Viatris | Leo Groothuis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | |
| Perrigo Co PLC | Patrick Lockwood-Taylor | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 23,454 | 23,454 | - | - | Restricted Stock Units | |
| Akamai Tech | F. Thomson Leighton | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 23,352 | 23,353 | - | - | Restricted Stock Units | |
| Akamai Tech | F. Thomson Leighton | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 23,352 | 133,110 (0%) | 0% | 0 | Common Stock | |
| Charles Schwab | Jonathan M. Craig | MD, Head of Investor Services | Sale of securities on an exchange or to another person at price $ 75.59 per share. | 06 Mar 2025 | 23,258 | 0 (0%) | 0% | 75.6 | 1,757,986 | Common Stock |
| Flutter Entertainment PLC | Amy Howe | CEO & President - FanDuel | 06 Mar 2025 | 23,181 | 49,404 | - | - | Restricted Stock Units | ||
| Flutter Entertainment PLC | Amy Howe | CEO & President - FanDuel | 06 Mar 2025 | 23,181 | 74,755 | - | 0 | Ordinary Shares | ||
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.28 per share. | 06 Mar 2025 | 22,752 | 751,738 (1%) | 0% | 14.3 | 324,828 | Class A Common Stock |
| Teradata Corp | Steve McMillan | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.98 per share. | 06 Mar 2025 | 22,650 | 595,867 (0%) | 0% | 23.0 | 520,497 | Common Stock |
| SBA Communications (Class A) | Brendan T. Cavanagh | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 22,516 | 22,516 | - | - | Performance Restricted Stock Units | |
| Kyntra Bio Inc | Thane Wettig | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 06 Mar 2025 | 22,038 | 397,915 (0%) | 0% | 0.4 | 8,595 | Common Stock |
| Nuvalent Inc (Class A) | Darlene Noci | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 71.92 per share. | 06 Mar 2025 | 22,016 | 52,340 | - | 71.9 | 1,583,391 | Class A Common Stock |
| Nuvalent Inc (Class A) | Darlene Noci | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 06 Mar 2025 | 21,985 | 70,019 | - | 1.1 | 23,744 | Class A Common Stock |
| Nuvalent Inc (Class A) | Darlene Noci | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 21,985 | 14,216 | - | - | Stock Option (Right to Buy) | |
| Indie Semiconductor Inc (Class A) | Michael Wittmann | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 21,750 | 88,762 | - | 0 | Class A Common Stock | |
| Indie Semiconductor Inc (Class A) | Michael Wittmann | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 21,750 | 0 | - | - | Restricted Stock Units | |
| Flutter Entertainment PLC | Jeremy Peter Jackson | Chief Executive Officer and Director | 06 Mar 2025 | 21,687 | 7,716 (0%) | 0% | 202.8 | 4,397,428 | Ords 0.09p | |
| Semtech Corp | Madhusudhan Rayabhari | SVP and GM | 06 Mar 2025 | 21,677 | 21,677 | - | - | Restricted Stock Unit | ||
| Arista Networks | Kenneth Duda | Director, CTO and SVP Software Eng. | Sale of securities on an exchange or to another person at price $ 85.92 per share. | 06 Mar 2025 | 21,284 | 1,384,996 (1%) | 0% | 85.9 | 1,828,674 | Common Stock |
| AMBAC Fin Grp Inc | Robert B. Eisman | Sr. MD & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 21,117 | 50,852 | - | - | Deferred Share Units | |
| CCC Intelligent Soln Holdings Inc | Mary Jo Prigge | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 21,115 | 166,030 | - | 0 | Common Stock | |
| CCC Intelligent Soln Holdings Inc | Mary Jo Prigge | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 21,115 | 42,230 | - | - | Restricted Stock Unit | |
| Stifel Fin Corp | James M. Zemlyak | Co-President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 20,827 | 83,306 | - | - | Phantom Stock Units | |
| LifeStance Health Grp Inc | Ujjwal Ramtekkar | Chief Medical Officer | 06 Mar 2025 | 20,805 | 140,325 | - | 0 | Common Stock | ||
| Skyward Specialty Insurance Grp Inc | Andrew Robinson | Director, CHAIRMAN & CEO | Sale of securities on an exchange or to another person at price $ 50.24 per share. | 06 Mar 2025 | 20,311 | 82,044 | - | 50.2 | 1,020,423 | Common Stock |
| Avanos Medical Inc | Joseph F. Woody | Former Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.30 per share. | 06 Mar 2025 | 20,249 | 402,776 (0%) | 0% | 15.3 | 309,810 | Common Stock |
| Masco | Jai Shah | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 20,230 | 39,638 (0%) | 0% | 0 | Common Stock | |
| SentinelOne Inc (Class A) | Richard Smith | President, Prod Tech & Ops | Sale of securities on an exchange or to another person at price $ 19.55 per share. | 06 Mar 2025 | 20,188 | 508,930 | - | 19.6 | 394,704 | Class A Common Stock |
| Heritage Global Inc | William Burnham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 20,000 | 50,000 | - | 0 | Common Stock | |
| Heritage Global Inc | Barbara A. Sinsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 20,000 | 81,300 | - | 0 | Common Stock | |
| Heritage Global Inc | Samuel L. Shimer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 20,000 | 332,500 | - | 0 | Common Stock | |
| Heritage Global Inc | Kelly Sharpe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 20,000 | 75,800 | - | 0 | Common Stock | |
| Heritage Global Inc | Michael Hexner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 20,000 | 252,104 | - | 0 | Common Stock | |
| Sandridge Energy Inc - Ordinary Shares New | Jonathan Frates | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 20,000 | 20,000 | - | - | Restricted Stock Unit | |
| LifeMD Inc | Maria Stan | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 20,000 | 68,125 | - | 0 | Common Stock | |
| LifeMD Inc | Maria Stan | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 20,000 | 48,125 | - | 0 | Common Stock | |
| Yelp Inc | Joseph R. Nachman | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 19,867 | 297,675 (0%) | 0% | 0 | Common Stock | |
| Yelp Inc | Joseph R. Nachman | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 33.97 per share. | 06 Mar 2025 | 19,811 | 291,189 (0%) | 0% | 34.0 | 672,990 | Common Stock |
| Solventum | Christopher Barry | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 19,805 | 19,805 | - | - | Restricted Stock Units | |
| GXO Logistics Inc | Elizabeth Fogarty | Chief Communications Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 19,686 | 19,686 | - | - | Restricted Stock Units | |
| GXO Logistics Inc | Richard Cawston | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 19,686 | 19,686 | - | - | Restricted Stock Units | |
| CCC Intelligent Soln Holdings Inc | Marc Fredman | SVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 19,515 | 58,545 | - | - | Restricted Stock Unit | |
| CCC Intelligent Soln Holdings Inc | Marc Fredman | SVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 19,515 | 278,406 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | Pablo Pantaleoni | Chief Digital Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.88 per share. | 06 Mar 2025 | 19,444 | 1,397,869 | - | 7.9 | 153,219 | Common Stock |
| LifeStance Health Grp Inc | Pablo Pantaleoni | Chief Digital Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.88 per share. | 06 Mar 2025 | 19,444 | 839,784 | - | 7.9 | 153,219 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | 06 Mar 2025 | 19,240 | 117,483 (0%) | 0% | 0 | Common Stock | ||
| Yelp Inc | David A. Schwarzbach | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 19,166 | 262,082 (0%) | 0% | 0 | Common Stock | |
| Yelp Inc | Sam Eaton | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 19,166 | 172,325 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Kenneth Duda | Director, CTO and SVP Software Eng. | Sale of securities on an exchange or to another person at price $ 84.71 per share. | 06 Mar 2025 | 18,996 | 41,867 (0%) | 0% | 84.7 | 1,609,088 | Common Stock |
| LifeStance Health Grp Inc | Ryan Pardo | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.88 per share. | 06 Mar 2025 | 18,919 | 841,733 | - | 7.9 | 149,082 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 18,765 | 18,765 | - | - | Restricted Stock Units |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.